Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Richardson

Thoracic Surgery (Cardiothoracic Vascular Surgery) Birmingham, AL Medical Doctor

NPI 1457390981 CMS profile 376190

2871 Acton Road, Suite 100, Birmingham, AL 35243

Open in the dashboard

General payments

$4,095

81 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Richardson of Birmingham, AL is reported in the CMS Open Payments database as having received $4,095 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $963 12
2024 General $311 9
2023 General $548 15
2022 General $277 6
2021 General $517 10
2020 General $400 9
2019 General $1,080 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Richardson
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to John Richardson were reported at $963. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year John Richardson Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,080 $886 $178–$3,167 $163
2020 $400 $341 $108–$1,605 $114
2021 $517 $453 $125–$1,886 $132
2022 $277 $695 $180–$2,566 $149
2023 $548 $745 $205–$2,662 $160
2024 $311 $799 $214–$2,967 $164
2025 $963 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $1,484 29 payments
  2. Baxter Healthcare $662 7 payments
  3. Edwards Lifesciences Corporation $366 5 payments
  4. Medtronic Vascular, Inc. $291 12 payments
  5. KLS-Martin L.P. $282 3 payments
  6. Ethicon US, LLC $231 7 payments
  7. Aziyo Biologics, Inc. $149 2 payments
  8. Atricure, Inc. $135 4 payments
  9. Bausch & Lomb, a division of Bausch Health US, LLC $119 1 payment
  10. Corcym Inc $118 3 payments
  11. Other $258 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,975 78 payments
  2. Education $120 3 payments
Products named General payments · program years 2019–2025
  1. Valiant Captivia $966 16 payments
  2. COSEAL $299 3 payments
  3. ENDURANT IIS $273 6 payments
  4. SAPIEN 3 Ultra RESILIA $217 2 payments
  5. ECM Patch,Pouch $149 2 payments
  6. Endurant $145 4 payments
  7. Avalus $124 1 payment
  8. VISTASEAL $123 4 payments
  9. Non-Franchise (NOF) - NonProduct $122 1 payment
  10. TACHOSIL $120 1 payment
  11. Other $1,285 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

61

Median for Cardiac Surgery: 68

Drug cost

$619

Median for Cardiac Surgery: $445

Branded share of claims

54.1%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Atorvastatin Calcium Generic 28 $474
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 33 $146

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$95,384

Medicare's payments for the services billed

Medicare patients

88

Average age 75

Services billed

304

33 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Atrial fibrillation 61%
Arthritis 53%
Diabetes 47%
Chronic kidney disease 44%
COPD 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record